Skip to main content

Table 2 Characteristics of the included studies in the review and meta-analysis, Ethiopia, 2019

From: Precancerous cervical lesion in Ethiopia: systematic review and meta-analysis

Author name Study year Region Method of assessment HIV status Study design Mean age Response rate (%) Sample size Total N outcome Prevalence (%) Quality score
Awoke et al. [27] 2017 Amhara VIA Both Cross-sectional 35 100% 428 61 14.3 100
Belayneh et al. [28] 2018 Amhara Pap smear HIV Cross-sectional 34.48 97.60% 284 28 9.9 75
Birra [29] 2016 Addis Ababa VIA NS Cross-sectional 35.73 99% 316 89 28.4 87.5
Gedefaw et al. [30] 2013 SNNPR VIA HIV Cross-sectional 33 98% 448 99 22.1 100
Getinet et al. [31] 2014 Amhara Pap stain Both Cross-sectional 35.02 97.80% 400 56 14.1 100
Hailemariam et al. [32] 2010 SNNPR Diagnosis logbook Both Cross-sectional 41.6 91.70% 2120 350 16.5 87.5
Kassa et al. [33] 2015 Amhara Women’s chart HIV Cross-sectional 35.9 100.00% 435 88 20.2 100
Kebede et al. [34] 2017 Tigray VIA Both Cross-sectional 32.95 100% 342 23 6.7 100
Meseret and Tadiwos [35] 2015 Addis Ababa VIA NS Cross-sectional 35.7 99% 226 54 24.1 100
Netsanet et al. [36] 2014 Addis Ababa VIA HIV Cross-sectional NR 100% 16632 1663 10 100
Pelzer et al. [37] 1992 Addis Ababa Cytological investigation NS Cross-sectional NR 90% 2111 33 1.56 62.5
Ruland et al. [38] 2006 SNNPR Digene HPV test NS Cross-sectional 34 100% 189 30 15.9 75
Sami-Ramzi et al. [39] 2006 SNNPR VIA NS Cross-sectional NR 100.00% 537 93 17.3 100
Teame et al. [40] 2016 Addis Ababa VIA Both Cross-sectional 39.87 95% 360 46 12.8 90
Teka et al. [41] 2017 SNNPR Women’s chart Both Cross-sectional NR 100% 528 146 27.7 100
Temesgen et al. [42] 2019 Amhara VIA Both Cross-sectional 36.26 100% 422 29 6.9 100
Zewdie et al. [43] 2013 Oromia VIA Both Cross-sectional 32.4 100.00% 334 43 12.9 100
  1. NS not stated, VIA visual inspection through acetic acid